Patel, Tapan P.
Aaberg, Michael T.
Paulus, Yannis M.
Lieu, Philip
Dedania, Vaidehi S.
Qian, Cynthia X.
Besirli, Cagri G.
Margolis, Todd
Fletcher, Daniel A.
Kim, Tyson N. http://orcid.org/0000-0002-5275-6614
Funding for this research was provided by:
Knights Templar Eye Foundation (Career Starter)
National Eye Institute (1K08EY027458)
Article History
Received: 7 July 2019
Revised: 27 August 2019
Accepted: 5 September 2019
First Online: 9 September 2019
Compliance with ethical standards
: This study was approved by the Institutional Review Board at the University of Michigan and Sparrow Hospital, Michigan State University. All research was conducted in compliance with human subjects regulations and adhered to the tenets of the Declaration of Helsinki. This study was registered onExternalRef removed, identifier NCT03076697.
: DAF is a co-founder of CellScope, Inc., a company commercializing a cellphone-based otoscope, and holds shares in CellScope, Inc. DAF and TNK are inventors on US patents and related applications pertaining to a “Retinal CellScope Apparatus.”